Invention Grant
- Patent Title: Use of IL-1 antagonists to treat gout
- Patent Title (中): 使用IL-1拮抗剂治疗痛风
-
Application No.: US12887529Application Date: 2010-09-22
-
Publication No.: US08114394B2Publication Date: 2012-02-14
- Inventor: Catherine Vicary , Scott Mellis
- Applicant: Catherine Vicary , Scott Mellis
- Applicant Address: US NY Tarrytown
- Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee Address: US NY Tarrytown
- Agent Valeta Gregg, Esq.; Frank R. Cottingham, Esq.
- Main IPC: A61K38/03
- IPC: A61K38/03 ; A61K38/16 ; A61K38/44 ; A61K31/195
Abstract:
Methods of treating, inhibiting, or ameliorating gout, including chronic acute (refractory) gout, pseudogout, or drug-induced gout, in a human subject in need thereof, comprising administering to a subject in need a therapeutic amount of an interleukin 1 (IL-1) antagonist, wherein the incidence of a gout flare is reduced or inhibited.
Public/Granted literature
- US20110008374A1 Use of IL-1 Antagonists to Treat Gout Public/Granted day:2011-01-13
Information query
IPC分类:
